HEADER LIGASE 05-JUL-23 8POT TITLE TERNARY COMPLEX OF E. COLI LEUCYL-TRNA SYNTHETASE, TRNA(LEU) AND THE TITLE 2 BENZOXABOROLE CMPD9 IN THE EDITING CONFORMATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: LEUCINE--TRNA LIGASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: LEUCYL-TRNA SYNTHETASE,LEURS; COMPND 5 EC: 6.1.1.4; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: TRNA(LEU); COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES; COMPND 11 OTHER_DETAILS: INHIBITOR CMPD9 FORMS A COVALENT ADDUCT WITH THE 3' COMPND 12 ADENOSINE BASE OF TRNA SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI K-12; SOURCE 3 ORGANISM_TAXID: 83333; SOURCE 4 GENE: LEUS, B0642, JW0637; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: RIL; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI K-12; SOURCE 12 ORGANISM_TAXID: 83333; SOURCE 13 OTHER_DETAILS: OBTAINED BY T7 POL IN VITRO TRANSCRIPTION KEYWDS LEUCINE TRNA LIGASE, ATP BINDING PROTEIN, TRNA AMINOACYLATION FOR KEYWDS 2 PROTEIN TRANSLATION, CYTOSOLIC REACTION CATALYSED: ATP + L-LEUCINE + KEYWDS 3 TRNA(LEU) = AMP + DIPHOSPHATE + L-LEUCYL-TRNA(LEU), LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR A.PALENCIA,G.HOFFMANN REVDAT 2 24-JUL-24 8POT 1 JRNL REVDAT 1 12-JUN-24 8POT 0 JRNL AUTH G.HOFFMANN,M.LUKARSKA,R.H.CLARE,E.K.G.MASTERS,K.L.JOHNSTON, JRNL AUTH 2 L.FORD,J.D.TURNER,S.A.WARD,M.J.TAYLOR,M.R.JENSEN,A.PALENCIA JRNL TITL TARGETING A MICROBIOTA WOLBACHIAN AMINOACYL-TRNA SYNTHETASE JRNL TITL 2 TO BLOCK ITS PATHOGENIC HOST. JRNL REF SCI ADV V. 10 O1453 2024 JRNL REFN ESSN 2375-2548 JRNL PMID 38985862 JRNL DOI 10.1126/SCIADV.ADO1453 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 58.06 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 68.3 REMARK 3 NUMBER OF REFLECTIONS : 44722 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2224 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.31 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 7.15 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2733 REMARK 3 BIN FREE R VALUE : 0.3112 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 37 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6496 REMARK 3 NUCLEIC ACID ATOMS : 1795 REMARK 3 HETEROGEN ATOMS : 55 REMARK 3 SOLVENT ATOMS : 377 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.21630 REMARK 3 B22 (A**2) : -0.38520 REMARK 3 B33 (A**2) : -0.83100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.51390 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.310 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.517 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.284 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.491 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.284 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.926 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.893 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 8738 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 12264 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2743 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 1236 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 8738 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 1189 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6344 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 0.85 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.11 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.57 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8POT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-JUL-23. REMARK 100 THE DEPOSITION ID IS D_1292131637. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-JAN-23 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : MASSIF-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96546 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC 1.0.5 REMARK 200 DATA SCALING SOFTWARE : STARANISO REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44722 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.149 REMARK 200 RESOLUTION RANGE LOW (A) : 58.056 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.2 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 58.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM ACETATE PH5.6, 0.2 M REMARK 280 NACL, 20% PEG6000, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 38.39700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5040 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 47990 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -19 REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PRO A -4 REMARK 465 ARG A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 ASN A 157 REMARK 465 TRP A 158 REMARK 465 CYS A 159 REMARK 465 PRO A 160 REMARK 465 ASN A 161 REMARK 465 ASP A 162 REMARK 465 GLN A 163 REMARK 465 THR A 164 REMARK 465 VAL A 165 REMARK 465 LEU A 166 REMARK 465 ALA A 167 REMARK 465 ASN A 168 REMARK 465 GLU A 169 REMARK 465 GLN A 170 REMARK 465 VAL A 171 REMARK 465 ILE A 172 REMARK 465 ASP A 173 REMARK 465 GLY A 174 REMARK 465 CYS A 175 REMARK 465 CYS A 176 REMARK 465 TRP A 177 REMARK 465 ARG A 178 REMARK 465 CYS A 179 REMARK 465 ASP A 180 REMARK 465 THR A 181 REMARK 465 LYS A 182 REMARK 465 VAL A 183 REMARK 465 GLU A 184 REMARK 465 LYS A 289 REMARK 465 VAL A 290 REMARK 465 ALA A 291 REMARK 465 GLU A 292 REMARK 465 ALA A 293 REMARK 465 GLU A 294 REMARK 465 MET A 295 REMARK 465 ALA A 296 REMARK 465 THR A 297 REMARK 465 LEU A 839 REMARK 465 ASP A 840 REMARK 465 GLY A 841 REMARK 465 VAL A 842 REMARK 465 THR A 843 REMARK 465 VAL A 844 REMARK 465 ARG A 845 REMARK 465 LYS A 846 REMARK 465 U B 34 REMARK 465 A B 35 REMARK 465 A B 76 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 G B 1 P G B 1 OP3 -0.124 REMARK 500 C B 17 O3' C B 17 C3' 0.080 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 G B 1 OP1 - P - OP2 ANGL. DEV. = -9.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 132 -65.56 -95.95 REMARK 500 ASN A 274 39.42 -89.68 REMARK 500 CYS A 505 57.38 -154.10 REMARK 500 GLU A 532 -9.39 -58.12 REMARK 500 MET A 536 -104.13 -116.62 REMARK 500 ALA A 693 33.80 -98.94 REMARK 500 THR A 721 78.80 -101.71 REMARK 500 LYS A 853 -58.84 -145.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8POQ RELATED DB: PDB REMARK 900 RELATED ID: 8POR RELATED DB: PDB REMARK 900 RELATED ID: 8POS RELATED DB: PDB DBREF 8POT A 1 860 UNP P07813 SYL_ECOLI 1 860 DBREF 8POT B 1 76 PDB 8POT 8POT 1 76 SEQADV 8POT MET A -19 UNP P07813 INITIATING METHIONINE SEQADV 8POT GLY A -18 UNP P07813 EXPRESSION TAG SEQADV 8POT SER A -17 UNP P07813 EXPRESSION TAG SEQADV 8POT SER A -16 UNP P07813 EXPRESSION TAG SEQADV 8POT HIS A -15 UNP P07813 EXPRESSION TAG SEQADV 8POT HIS A -14 UNP P07813 EXPRESSION TAG SEQADV 8POT HIS A -13 UNP P07813 EXPRESSION TAG SEQADV 8POT HIS A -12 UNP P07813 EXPRESSION TAG SEQADV 8POT HIS A -11 UNP P07813 EXPRESSION TAG SEQADV 8POT HIS A -10 UNP P07813 EXPRESSION TAG SEQADV 8POT SER A -9 UNP P07813 EXPRESSION TAG SEQADV 8POT SER A -8 UNP P07813 EXPRESSION TAG SEQADV 8POT GLY A -7 UNP P07813 EXPRESSION TAG SEQADV 8POT LEU A -6 UNP P07813 EXPRESSION TAG SEQADV 8POT VAL A -5 UNP P07813 EXPRESSION TAG SEQADV 8POT PRO A -4 UNP P07813 EXPRESSION TAG SEQADV 8POT ARG A -3 UNP P07813 EXPRESSION TAG SEQADV 8POT GLY A -2 UNP P07813 EXPRESSION TAG SEQADV 8POT SER A -1 UNP P07813 EXPRESSION TAG SEQADV 8POT HIS A 0 UNP P07813 EXPRESSION TAG SEQRES 1 A 880 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 880 LEU VAL PRO ARG GLY SER HIS MET GLN GLU GLN TYR ARG SEQRES 3 A 880 PRO GLU GLU ILE GLU SER LYS VAL GLN LEU HIS TRP ASP SEQRES 4 A 880 GLU LYS ARG THR PHE GLU VAL THR GLU ASP GLU SER LYS SEQRES 5 A 880 GLU LYS TYR TYR CYS LEU SER MET LEU PRO TYR PRO SER SEQRES 6 A 880 GLY ARG LEU HIS MET GLY HIS VAL ARG ASN TYR THR ILE SEQRES 7 A 880 GLY ASP VAL ILE ALA ARG TYR GLN ARG MET LEU GLY LYS SEQRES 8 A 880 ASN VAL LEU GLN PRO ILE GLY TRP ASP ALA PHE GLY LEU SEQRES 9 A 880 PRO ALA GLU GLY ALA ALA VAL LYS ASN ASN THR ALA PRO SEQRES 10 A 880 ALA PRO TRP THR TYR ASP ASN ILE ALA TYR MET LYS ASN SEQRES 11 A 880 GLN LEU LYS MET LEU GLY PHE GLY TYR ASP TRP SER ARG SEQRES 12 A 880 GLU LEU ALA THR CYS THR PRO GLU TYR TYR ARG TRP GLU SEQRES 13 A 880 GLN LYS PHE PHE THR GLU LEU TYR LYS LYS GLY LEU VAL SEQRES 14 A 880 TYR LYS LYS THR SER ALA VAL ASN TRP CYS PRO ASN ASP SEQRES 15 A 880 GLN THR VAL LEU ALA ASN GLU GLN VAL ILE ASP GLY CYS SEQRES 16 A 880 CYS TRP ARG CYS ASP THR LYS VAL GLU ARG LYS GLU ILE SEQRES 17 A 880 PRO GLN TRP PHE ILE LYS ILE THR ALA TYR ALA ASP GLU SEQRES 18 A 880 LEU LEU ASN ASP LEU ASP LYS LEU ASP HIS TRP PRO ASP SEQRES 19 A 880 THR VAL LYS THR MET GLN ARG ASN TRP ILE GLY ARG SER SEQRES 20 A 880 GLU GLY VAL GLU ILE THR PHE ASN VAL ASN ASP TYR ASP SEQRES 21 A 880 ASN THR LEU THR VAL TYR THR THR ARG PRO ASP THR PHE SEQRES 22 A 880 MET GLY CYS THR TYR LEU ALA VAL ALA ALA GLY HIS PRO SEQRES 23 A 880 LEU ALA GLN LYS ALA ALA GLU ASN ASN PRO GLU LEU ALA SEQRES 24 A 880 ALA PHE ILE ASP GLU CYS ARG ASN THR LYS VAL ALA GLU SEQRES 25 A 880 ALA GLU MET ALA THR MET GLU LYS LYS GLY VAL ASP THR SEQRES 26 A 880 GLY PHE LYS ALA VAL HIS PRO LEU THR GLY GLU GLU ILE SEQRES 27 A 880 PRO VAL TRP ALA ALA ASN PHE VAL LEU MET GLU TYR GLY SEQRES 28 A 880 THR GLY ALA VAL MET ALA VAL PRO GLY HIS ASP GLN ARG SEQRES 29 A 880 ASP TYR GLU PHE ALA SER LYS TYR GLY LEU ASN ILE LYS SEQRES 30 A 880 PRO VAL ILE LEU ALA ALA ASP GLY SER GLU PRO ASP LEU SEQRES 31 A 880 SER GLN GLN ALA LEU THR GLU LYS GLY VAL LEU PHE ASN SEQRES 32 A 880 SER GLY GLU PHE ASN GLY LEU ASP HIS GLU ALA ALA PHE SEQRES 33 A 880 ASN ALA ILE ALA ASP LYS LEU THR ALA MET GLY VAL GLY SEQRES 34 A 880 GLU ARG LYS VAL ASN TYR ARG LEU ARG ASP TRP GLY VAL SEQRES 35 A 880 SER ARG GLN ARG TYR TRP GLY ALA PRO ILE PRO MET VAL SEQRES 36 A 880 THR LEU GLU ASP GLY THR VAL MET PRO THR PRO ASP ASP SEQRES 37 A 880 GLN LEU PRO VAL ILE LEU PRO GLU ASP VAL VAL MET ASP SEQRES 38 A 880 GLY ILE THR SER PRO ILE LYS ALA ASP PRO GLU TRP ALA SEQRES 39 A 880 LYS THR THR VAL ASN GLY MET PRO ALA LEU ARG GLU THR SEQRES 40 A 880 ASP THR PHE ASP THR PHE MET GLU SER SER TRP TYR TYR SEQRES 41 A 880 ALA ARG TYR THR CYS PRO GLN TYR LYS GLU GLY MET LEU SEQRES 42 A 880 ASP SER GLU ALA ALA ASN TYR TRP LEU PRO VAL ASP ILE SEQRES 43 A 880 TYR ILE GLY GLY ILE GLU HIS ALA ILE MET HIS LEU LEU SEQRES 44 A 880 TYR PHE ARG PHE PHE HIS LYS LEU MET ARG ASP ALA GLY SEQRES 45 A 880 MET VAL ASN SER ASP GLU PRO ALA LYS GLN LEU LEU CYS SEQRES 46 A 880 GLN GLY MET VAL LEU ALA ASP ALA PHE TYR TYR VAL GLY SEQRES 47 A 880 GLU ASN GLY GLU ARG ASN TRP VAL SER PRO VAL ASP ALA SEQRES 48 A 880 ILE VAL GLU ARG ASP GLU LYS GLY ARG ILE VAL LYS ALA SEQRES 49 A 880 LYS ASP ALA ALA GLY HIS GLU LEU VAL TYR THR GLY MET SEQRES 50 A 880 SER LYS MET SER LYS SER LYS ASN ASN GLY ILE ASP PRO SEQRES 51 A 880 GLN VAL MET VAL GLU ARG TYR GLY ALA ASP THR VAL ARG SEQRES 52 A 880 LEU PHE MET MET PHE ALA SER PRO ALA ASP MET THR LEU SEQRES 53 A 880 GLU TRP GLN GLU SER GLY VAL GLU GLY ALA ASN ARG PHE SEQRES 54 A 880 LEU LYS ARG VAL TRP LYS LEU VAL TYR GLU HIS THR ALA SEQRES 55 A 880 LYS GLY ASP VAL ALA ALA LEU ASN VAL ASP ALA LEU THR SEQRES 56 A 880 GLU ASN GLN LYS ALA LEU ARG ARG ASP VAL HIS LYS THR SEQRES 57 A 880 ILE ALA LYS VAL THR ASP ASP ILE GLY ARG ARG GLN THR SEQRES 58 A 880 PHE ASN THR ALA ILE ALA ALA ILE MET GLU LEU MET ASN SEQRES 59 A 880 LYS LEU ALA LYS ALA PRO THR ASP GLY GLU GLN ASP ARG SEQRES 60 A 880 ALA LEU MET GLN GLU ALA LEU LEU ALA VAL VAL ARG MET SEQRES 61 A 880 LEU ASN PRO PHE THR PRO HIS ILE CYS PHE THR LEU TRP SEQRES 62 A 880 GLN GLU LEU LYS GLY GLU GLY ASP ILE ASP ASN ALA PRO SEQRES 63 A 880 TRP PRO VAL ALA ASP GLU LYS ALA MET VAL GLU ASP SER SEQRES 64 A 880 THR LEU VAL VAL VAL GLN VAL ASN GLY LYS VAL ARG ALA SEQRES 65 A 880 LYS ILE THR VAL PRO VAL ASP ALA THR GLU GLU GLN VAL SEQRES 66 A 880 ARG GLU ARG ALA GLY GLN GLU HIS LEU VAL ALA LYS TYR SEQRES 67 A 880 LEU ASP GLY VAL THR VAL ARG LYS VAL ILE TYR VAL PRO SEQRES 68 A 880 GLY LYS LEU LEU ASN LEU VAL VAL GLY SEQRES 1 B 87 G C C C G G A U G G U G G SEQRES 2 B 87 A A U C G G U A G A C A C SEQRES 3 B 87 A A G G G A U U U A A A A SEQRES 4 B 87 U C C C U C G G C G U U C SEQRES 5 B 87 G C G C U G U G C G G G U SEQRES 6 B 87 U C A A G U C C C G C U C SEQRES 7 B 87 C G G G U A C C A HET EDO A 901 4 HET EDO A 902 4 HET 7RZ B 101 47 HETNAM EDO 1,2-ETHANEDIOL HETNAM 7RZ [(1R,3'S,5S,6R,8R)-3'-(AMINOMETHYL)-8-(6-AMINOPURIN-9- HETNAM 2 7RZ YL)-4'-BROMANYL-7'-[3-[METHYL-(PHENYLMETHYL) HETNAM 3 7RZ AMINO]PROPOXY]SPIRO[2,4,7-TRIOXA-3$L^{4}- HETNAM 4 7RZ BORABICYCLO[3.3.0]OCTANE-3,1'-3H-2,1$L^{4}- HETNAM 5 7RZ BENZOXABOROLE]-6-YL]METHYL DIHYDROGEN PHOSPHATE HETSYN EDO ETHYLENE GLYCOL HETSYN 7RZ AMP ADDUCT WITH 3-[[(3S)-3-(AMINOMETHYL)-4-BROMANYL-1, HETSYN 2 7RZ 3-DIHYDRO-2,1-BENZOXABOROL-7-YL]OXY]-N-METHYL-N- HETSYN 3 7RZ (PHENYLMETHYL)PROPAN-1-AMINE FORMUL 3 EDO 2(C2 H6 O2) FORMUL 5 7RZ C29 H35 B BR N7 O9 P FORMUL 6 HOH *377(H2 O) HELIX 1 AA1 ARG A 6 GLU A 9 5 4 HELIX 2 AA2 ILE A 10 ARG A 22 1 13 HELIX 3 AA3 HIS A 49 LEU A 69 1 21 HELIX 4 AA4 GLY A 83 ASN A 93 1 11 HELIX 5 AA5 ALA A 96 LEU A 115 1 20 HELIX 6 AA6 ASP A 120 GLU A 124 5 5 HELIX 7 AA7 THR A 129 LYS A 146 1 18 HELIX 8 AA8 ILE A 195 ALA A 197 5 3 HELIX 9 AA9 TYR A 198 ASP A 205 1 8 HELIX 10 AB1 LEU A 206 LEU A 209 5 4 HELIX 11 AB2 PRO A 213 GLY A 225 1 13 HELIX 12 AB3 ARG A 249 CYS A 256 5 8 HELIX 13 AB4 HIS A 265 ALA A 272 1 8 HELIX 14 AB5 ASN A 275 ASN A 287 1 13 HELIX 15 AB6 ASP A 342 GLY A 353 1 12 HELIX 16 AB7 SER A 384 ASN A 388 5 5 HELIX 17 AB8 ASP A 391 MET A 406 1 16 HELIX 18 AB9 PRO A 446 LEU A 450 5 5 HELIX 19 AC1 SER A 465 ASP A 470 1 6 HELIX 20 AC2 ASP A 470 ALA A 474 1 5 HELIX 21 AC3 THR A 492 SER A 497 1 6 HELIX 22 AC4 TRP A 498 TYR A 503 1 6 HELIX 23 AC5 ASP A 514 LEU A 522 1 9 HELIX 24 AC6 GLY A 530 ALA A 534 5 5 HELIX 25 AC7 MET A 536 ALA A 551 1 16 HELIX 26 AC8 SER A 587 VAL A 589 5 3 HELIX 27 AC9 ASP A 629 GLY A 638 1 10 HELIX 28 AD1 GLY A 638 ALA A 649 1 12 HELIX 29 AD2 GLN A 659 ALA A 682 1 24 HELIX 30 AD3 THR A 695 ARG A 718 1 24 HELIX 31 AD4 THR A 721 ALA A 737 1 17 HELIX 32 AD5 GLY A 743 ASN A 762 1 20 HELIX 33 AD6 THR A 765 LEU A 776 1 12 HELIX 34 AD7 GLU A 792 VAL A 796 5 5 HELIX 35 AD8 THR A 821 GLU A 832 1 12 HELIX 36 AD9 GLU A 832 TYR A 838 1 7 SHEET 1 AA1 4 ASN A 72 LEU A 74 0 SHEET 2 AA1 4 LYS A 34 SER A 39 1 N TYR A 35 O LEU A 74 SHEET 3 AA1 4 VAL A 524 GLY A 529 1 O ILE A 526 N LEU A 38 SHEET 4 AA1 4 ALA A 560 CYS A 565 1 O LEU A 564 N TYR A 527 SHEET 1 AA2 2 GLY A 78 TRP A 79 0 SHEET 2 AA2 2 LEU A 125 ALA A 126 1 O LEU A 125 N TRP A 79 SHEET 1 AA3 3 VAL A 149 ALA A 155 0 SHEET 2 AA3 3 GLU A 187 ILE A 193 -1 O GLN A 190 N LYS A 152 SHEET 3 AA3 3 TRP A 420 GLY A 421 -1 O TRP A 420 N ILE A 193 SHEET 1 AA4 6 THR A 242 THR A 247 0 SHEET 2 AA4 6 SER A 227 ASN A 237 -1 N ILE A 232 O VAL A 245 SHEET 3 AA4 6 GLY A 302 VAL A 310 -1 O LYS A 308 N ASN A 237 SHEET 4 AA4 6 GLU A 317 ALA A 323 -1 O ALA A 322 N VAL A 303 SHEET 5 AA4 6 TYR A 258 ALA A 262 1 N VAL A 261 O ALA A 323 SHEET 6 AA4 6 ALA A 334 ALA A 337 -1 O ALA A 337 N TYR A 258 SHEET 1 AA5 3 THR A 242 THR A 247 0 SHEET 2 AA5 3 SER A 227 ASN A 237 -1 N ILE A 232 O VAL A 245 SHEET 3 AA5 3 GLY A 409 ASN A 414 -1 O GLU A 410 N GLU A 231 SHEET 1 AA6 2 SER A 423 ARG A 424 0 SHEET 2 AA6 2 THR A 489 PHE A 490 -1 O THR A 489 N ARG A 424 SHEET 1 AA7 4 VAL A 442 PRO A 444 0 SHEET 2 AA7 4 MET A 434 LEU A 437 -1 N VAL A 435 O MET A 443 SHEET 3 AA7 4 MET A 481 ARG A 485 -1 O LEU A 484 N THR A 436 SHEET 4 AA7 4 LYS A 475 VAL A 478 -1 N VAL A 478 O MET A 481 SHEET 1 AA8 3 ARG A 583 VAL A 586 0 SHEET 2 AA8 3 VAL A 569 VAL A 577 -1 N TYR A 576 O ASN A 584 SHEET 3 AA8 3 VAL A 613 LYS A 619 -1 O THR A 615 N ALA A 573 SHEET 1 AA9 3 ARG A 583 VAL A 586 0 SHEET 2 AA9 3 VAL A 569 VAL A 577 -1 N TYR A 576 O ASN A 584 SHEET 3 AA9 3 LEU A 656 GLU A 657 1 O LEU A 656 N LEU A 570 SHEET 1 AB1 2 ALA A 591 ARG A 595 0 SHEET 2 AB1 2 ILE A 601 ASP A 606 -1 O LYS A 605 N ILE A 592 SHEET 1 AB2 4 LYS A 809 PRO A 817 0 SHEET 2 AB2 4 SER A 799 VAL A 806 -1 N VAL A 802 O ILE A 814 SHEET 3 AB2 4 LEU A 854 LEU A 857 1 O LEU A 855 N GLN A 805 SHEET 4 AB2 4 ILE A 848 VAL A 850 -1 N VAL A 850 O LEU A 854 LINK O3' C B 75 P 7RZ B 101 1555 1555 1.53 CISPEP 1 LEU A 450 PRO A 451 0 5.15 CISPEP 2 LEU A 522 PRO A 523 0 -2.11 CRYST1 89.167 76.794 90.863 90.00 102.55 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011215 0.000000 0.002497 0.00000 SCALE2 0.000000 0.013022 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011275 0.00000